Kujawiak
Takeda

KUJAWIAK Study

The relationship between disease activity and quality of life, fatigue, mood and sleep disturbances in patients with moderate to severe ulcerative colitis or Crohn's disease treated with vedolizumab.

PROSPECTIVE OBSERVATIONAL STUDY BASED ON PATIENT SELF-ASSESSMENT QUESTIONNAIRES.

Dear Doctors,
 

We invite you to participate in a multicenter observational study titled: "The relationship between disease activity and quality of life, fatigue, mood, and sleep disturbances in patients with moderate to severe ulcerative colitis or Crohn's disease treated with vedolizumab - a prospective observational study based on patient self-assessment questionnaires."

To start the study, it is necessary to conclude an online agreement. Therefore, please register and follow the instructions appearing on the computer screen.

After successful registration and electronic signing of the agreement, please log in using the data obtained during the account creation process.

BioStat® company oversees the smooth course of the study and data analysis.

All inquiries should be directed to the Organizer's office.

BioStat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
tel: 666 069 814
email: [email protected]

BioStat. Centrum Badawczo-Rozwojowe.
PL/EYV/19/0077b

Please fill out the registration form and join the study.

Registration form

Study sponsor

Takeda Pharma sp. z o.o.
Prosta 68, 00-838 Warsaw, Poland
tel: +48 22 608 13 00/01
fax: +48 22 608 13 03

Please log in using the data obtained after concluding the online agreement.

Forgot your password?